Study: Type 2 Diabetes Drugs Have Elevated AEs for Pancreatitis, Hypoglycemia and Ketoacidosis

Drug Industry Daily
Type 2 diabetes drugs have elevated reporting rates for pancreatitis, hypoglycemia and diabetic ketoacidosis, which adds to suspicions of class-wide side effect issues, especially for DPP-4 drugs, a new analysis from Advera Health Analytics said.

To View This Article:


Subscribe To Drug Industry Daily